Merus BV Correlations

MRUS Stock

USD 47.00 0.61 1.31%

The current 90-days correlation between Merus BV and Adagene is 0.12 (i.e., Average diversification). The correlation of Merus BV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Merus BV Correlation With Market

Good diversification

The correlation between Merus BV and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Merus BV and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merus BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Merus Stock please use our How to Invest in Merus BV guide.

Moving together with Merus Stock

0.81	DVAX	Dynavax Technologies	Pair Corr
0.61	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Merus Stock

0.84	VCEL	Vericel Corp Ord	Pair Corr
0.79	A	Agilent Technologies	Pair Corr
0.77	DRTS	Alpha Tau Medical	Pair Corr
0.76	VCYT	Veracyte	Pair Corr
0.69	DNLI	Denali Therapeutics	Pair Corr
0.65	ME	23Andme Holding	Pair Corr
0.57	SABSW	SAB Biotherapeutics	Pair Corr
0.52	VANI	Vivani Medical Earnings Call This Week	Pair Corr
0.48	VERA	Vera Therapeutics	Pair Corr
0.44	CDIOW	Cardio Diagnostics	Pair Corr
0.4	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.72	ELAN	Elanco Animal Health	Pair Corr
0.65	VXRT	Vaxart Inc	Pair Corr
0.63	ELEV	Elevation Oncology	Pair Corr
0.6	VRPX	Virpax Pharmaceuticals	Pair Corr
0.57	VYGR	Voyager Therapeutics	Pair Corr
0.55	VRDN	Viridian Therapeutics	Pair Corr
0.52	VRAX	Virax Biolabs Group	Pair Corr
0.52	VTRS	Viatris	Pair Corr
0.51	VTYX	Ventyx Biosciences	Pair Corr
0.5	ELDN	Eledon Pharmaceuticals Earnings Call This Week	Pair Corr
0.41	DYAI	Dyadic International Earnings Call This Week	Pair Corr
0.32	VYNE	Vyne Therapeutics	Pair Corr

Related Correlations Analysis

	ANEB	ADAG	ACRV	ANAB	MLYS	CRNX	INBX	LYEL	KRON	KURA
ANEB		-0.43	0.04	-0.13	0.17	0.16	0.24	-0.4	0.25	0.01	ANEB
ADAG	-0.43		0.49	-0.09	0.3	0.5	0.45	0.76	-0.15	0.36	ADAG
ACRV	0.04	0.49		-0.14	0.33	0.83	0.56	0.38	0.1	0.81	ACRV
ANAB	-0.13	-0.09	-0.14		-0.13	-0.32	-0.34	0.25	0.5	-0.06	ANAB
MLYS	0.17	0.3	0.33	-0.13		0.46	0.65	0.15	-0.41	0.24	MLYS
CRNX	0.16	0.5	0.83	-0.32	0.46		0.75	0.36	0.0	0.8	CRNX
INBX	0.24	0.45	0.56	-0.34	0.65	0.75		0.32	-0.24	0.39	INBX
LYEL	-0.4	0.76	0.38	0.25	0.15	0.36	0.32		0.1	0.38	LYEL
KRON	0.25	-0.15	0.1	0.5	-0.41	0.0	-0.24	0.1		0.17	KRON
KURA	0.01	0.36	0.81	-0.06	0.24	0.8	0.39	0.38	0.17		KURA
	ANEB	ADAG	ACRV	ANAB	MLYS	CRNX	INBX	LYEL	KRON	KURA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CRNX	+ 0.83	ACRV
KURA	+ 0.81	ACRV
KURA	+ 0.8	CRNX
LYEL	+ 0.76	ADAG
INBX	+ 0.75	CRNX
INBX	+ 0.65	MLYS

High negative correlations

ADAG	- 0.43	ANEB
KRON	- 0.41	MLYS
LYEL	- 0.4	ANEB
INBX	- 0.34	ANAB
CRNX	- 0.32	ANAB
KRON	- 0.24	INBX

Risk-Adjusted Indicators

There is a big difference between Merus Stock performing well and Merus BV Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Merus BV's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ANEB	5.34	0.59	0.10	0.35	5.29	(7.25)	19.58	(10.43)	40.87
ADAG	3.05	(0.08)	0.00	0.25	0.00	0.00	4.62	(8.25)	41.45
ACRV	4.16	(0.07)	0.00	(0.14)	0.00	0.00	10.17	(8.24)	30.57
ANAB	4.66	(0.10)	0.00	(0.16)	0.00	0.00	9.84	(9.33)	43.41
MLYS	4.27	0.28	0.11	(0.25)	4.47	(4.99)	10.04	(8.23)	50.53
CRNX	2.73	(0.64)	0.00	(0.88)	0.00	0.00	3.78	(7.53)	21.52
INBX	2.51	0.02	0.00	(0.07)	0.00	0.00	5.73	(5.63)	16.41
LYEL	3.99	(0.75)	0.00	(0.72)	0.00	0.00	6.56	(9.23)	20.34
KRON	1.70	(0.10)	0.00	(0.23)	0.00	0.00	3.19	(3.03)	12.10
KURA	2.34	(0.39)	0.00	(0.53)	0.00	0.00	4.48	(5.58)	13.72

Merus BV Corporate Management

Peter JD	Company EVP	Profile
Ashley PharmD	Senior Affairs	Profile
Kathleen Farren	IR Officer	Profile
Gregory Perry	Chief Officer	Profile
Hennie Hoogenboom	CoFounder Advisor	Profile
Alexander Bakker	Chief VP	Profile
Cecilia Geuijen	Chief VP	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC